Vaccinex, Inc.
VCNX· OTC
VCNXVaccinex, Inc.
Filed Aug 14, 2018 · 10-Q · 45 days after period end · 0001564590-18-021566
| Metric | Q2 2018 | Q2 2017 |
|---|---|---|
| Revenue | $126.00K | — |
| Net Income | -$6.61M | -$4.88M |
| EPS Diluted | -$6.72 | -$5.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaccinex, Inc. · CIK 1205922 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Aug 14, 2018 · 45 d after period end
